The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-fluoro-4-(5-methyl-6-(3-morpholinopropylcarbamoyl)pyrrolo[1,2-f][1,2,4]triazin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide ID: ALA4285034
PubChem CID: 145991046
Max Phase: Preclinical
Molecular Formula: C32H33F2N7O5
Molecular Weight: 633.66
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(C(=O)NCCCN2CCOCC2)cn2ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12
Standard InChI: InChI=1S/C32H33F2N7O5/c1-20-24(28(42)35-11-2-12-40-13-15-45-16-14-40)18-41-27(20)29(36-19-37-41)46-26-8-7-23(17-25(26)34)39-31(44)32(9-10-32)30(43)38-22-5-3-21(33)4-6-22/h3-8,17-19H,2,9-16H2,1H3,(H,35,42)(H,38,43)(H,39,44)
Standard InChI Key: UEPPBJWMOQEIAS-UHFFFAOYSA-N
Molfile:
RDKit 2D
46 51 0 0 0 0 0 0 0 0999 V2000
11.4943 -16.1457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9071 -16.8556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3155 -16.1432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6764 -20.9607 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3860 -20.5513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3832 -19.7286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6746 -19.3234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9683 -20.5518 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9650 -19.7353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1875 -19.4861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7101 -20.1486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1928 -20.8072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9318 -18.7099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8929 -20.1519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4815 -19.4459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4872 -20.8613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6719 -18.5062 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3783 -18.0953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0855 -18.5038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7914 -18.0936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7893 -17.2756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0753 -16.8694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3723 -17.2820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6616 -16.8785 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.4951 -16.8638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2047 -17.2691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2084 -18.0863 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6201 -17.2627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3259 -16.8509 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6238 -18.0799 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0355 -17.2562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0377 -18.0742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7464 -18.4795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4532 -18.0676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4469 -17.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7376 -16.8446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1633 -18.4720 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.6701 -20.8647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2644 -21.5740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4472 -21.5774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0415 -22.2867 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2275 -22.2898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8219 -22.9951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2299 -23.7035 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0480 -23.7021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4582 -22.9923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
1 3 1 0
8 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 9 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 8 1 0
10 13 1 0
11 14 1 0
14 15 2 0
14 16 1 0
7 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
23 24 1 0
21 25 1 0
25 26 1 0
26 2 1 0
26 27 2 0
2 28 1 0
28 29 1 0
28 30 2 0
29 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 31 1 0
34 37 1 0
16 38 1 0
38 39 1 0
39 40 1 0
40 41 1 0
41 42 1 0
41 46 1 0
42 43 1 0
43 44 1 0
44 45 1 0
45 46 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 633.66Molecular Weight (Monoisotopic): 633.2511AlogP: 3.92#Rotatable Bonds: 11Polar Surface Area: 139.19Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.10CX Basic pKa: 6.94CX LogP: 3.82CX LogD: 3.69Aromatic Rings: 4Heavy Atoms: 46QED Weighted: 0.17Np Likeness Score: -1.60
References 1. Shi W, Qiang H, Huang D, Bi X, Huang W, Qian H.. (2018) Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2., 158 [PMID:30248654 ] [10.1016/j.ejmech.2018.09.050 ]